New Owner
Novo Nordisk - Xellia Pharmaceuticals
Novo Nordisk acquires Xellia Pharmaceuticals
Announced: May 21, 2013
Type: Acquisition
Status: Pending
Amount: $ 700,000,000
Acquisition News
Add News| Date | Title | |
|---|---|---|
| May 21, 2013 | Business Wire - Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million |
|
Novo Nordisk Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Aug 27, 2015 |
|
Undisclosed amount |
| Aug 27, 2015 |
|
Undisclosed amount |
